Incidence of glycopeptide heterointermediate Staphylococcus aureus strains in Maltese hospitals

Clinical Microbiology and Infection

Volumn 11, Issue 5, 2005, Pages 405-407

  Borg, Michael A ^a   Zerafa, R ^a   Morrison, D ^b   Cuschieri, P ^a  

^a ST LUKE S HOSPITAL   (Malta)

^b Scottish MRSA Reference Laboratory   (United Kingdom)

Author keywords

h GISA; Malta; Resistance; Staphylococcus aureus; Teicoplanin; Vancomycin

Indexed keywords

AGAR; CEFUROXIME; CIPROFLOXACIN; ERYTHROMYCIN; LINCOMYCIN; METICILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; ENDEMIC DISEASE; GENOTYPE; INCIDENCE; MALTA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREDICTION; PRIORITY JOURNAL; SCREENING; STAPHYLOCOCCUS AUREUS; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION;

STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; HOSPITALS; HUMANS; INCIDENCE; MALTA; METHICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICOPLANIN; VANCOMYCIN;

EID: 17744387354     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2005.01110.x     Document Type: Article

References (16)

1. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136.
2. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-1673.
3. Tenover FC, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerg Infect Dis 2001; 7: 327-332.
4. Ploy MC, Grelaud C, Martin C, De Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
5. Johnson AP. Intermediate vancomycin resistance in Staphylococcus aureus: a major threat or a minor inconvenience. J Antimicrob Chemother 1998; 42: 289-291.
6. European Antimicrobial Resistance Surveillance System. Technical guide for the detection of VISA/VRSA. Bilthoven: National Institute for Public Health and the Environment (RIVM), 2004. http://www.earss.rivm.nl.
7. Walsh TR, Bolmström A, Qwärnström A et al. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001; 39: 2439-2444.
8. Chesneau O, Morvan A, Solh NE. Retrospective screening for heterogeneous vancomycin resistance in diverse Staphylococcus aureus clones disseminated in French hospitals. J Antimicrob Chemother 2000; 45: 887-890.
9. MacKenzie FM, Greig P, Morrison D, Edwards G, Gould IM. Identification and characterization of teicoplanin-intermediate Staphylococcus aureus blood culture isolates in NE Scotland. J Antimicrob Chemother 2002; 50: 689-697.
10. Kumari DN, Keer V, Hawkey PM et al. Comparison and application of ribosome spacer DNA amplicon polymorphisms and pulsed-field gel electrophoresis for differentiation of methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 1997; 35: 881-885.
11. Marchese A, Balistreri G, Tonoli E, Debbia EA, Schito GC. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol 2000; 38: 866-869.
12. Vandenesch F, Naimi T, Enright MC et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9: 978-984.
13. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann Rev Microbiol 2002; 56: 657-675.
14. Ariza J, Pujol M, Cabo J et al. Vancomycin in surgical infections due to methicillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin. Lancet 1999; 353: 1587-1588.
15. Reverdy ME, Jarraud S, Bobin-Dubreux S et al. Incidence of Staphylococcus aureus with reduced susceptibility to glycopeptides in two French hospitals. Clin Microbiol Infect 2001; 7: 267-272.
16. Hageman JC, Pegues DA, Jepson C et al. Vancomycin-intermediate Staphylococcus aureus in a home health-care patient. Emerg Infect Dis 2001; 7: 1023-1025.